Kris MG - Search Results

1

Phase II trials of ondansetron with high-dose cisplatin.

Kris MG. Kris MG. Semin Oncol. 1992 Aug;19(4 Suppl 10):23-7. Semin Oncol. 1992. PMID: 1387247 Review.

2

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA. Grant SC, et al. Among authors: kris mg. J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484. J Clin Oncol. 1992. PMID: 1311028

3

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

Kris MG, Tyson LB, Clark RA, Gralla RJ. Kris MG, et al. Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Cancer. 1992. PMID: 1386282 Review.

4

Rationale for combination antiemetic therapy and strategies for the use of ondansetron in combinations.

Kris MG. Kris MG. Semin Oncol. 1992 Aug;19(4 Suppl 10):61-6. Semin Oncol. 1992. PMID: 1387252 Review.

5

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: kris mg. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

6

Management of nausea and vomiting caused by anticancer drugs: state of the art.

Pisters KM, Kris MG. Pisters KM, et al. Among authors: kris mg. Oncology (Williston Park). 1992 Feb;6(2 Suppl):99-104. Oncology (Williston Park). 1992. PMID: 1532744 Review.

7

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: kris mg. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

8

Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.

Markman M, D'Acquisto R, Iannotti N, Kris M, Hakes T, Bajorin D, Bosl G, Reichman B, Casper E, Magill G, et al. Markman M, et al. J Cancer Res Clin Oncol. 1991;117(2):151-5. doi: 10.1007/BF01613139. J Cancer Res Clin Oncol. 1991. PMID: 2007612 Clinical Trial.

9

Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin.

Kris MG, Gralla RJ, Clark RA, Tyson LB. Kris MG, et al. J Natl Cancer Inst. 1989 Jan 4;81(1):42-6. doi: 10.1093/jnci/81.1.42. J Natl Cancer Inst. 1989. PMID: 2521184 Clinical Trial.

10

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters